# Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

> **NCT05335434** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 20 (estimated)

## Conditions studied

- Myeloablative Allogeneic Hematopoietic Cell Transplantation
- Intraoral Photobiomodulation Therapy
- Oral Mucositis
- Mucosal Ulcer

## Interventions

- **DEVICE:** THOR LX2.3 with LED Lollipop

## Key facts

- **NCT ID:** NCT05335434
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-10
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-07-19
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05335434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05335434, "Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05335434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*